Nexo Therapeutics
PrivateLast Round
Series B
Mar 27, 2026
Total Funding Raised
$60M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Nexo Therapeutics is a biotechnology company that develops small-molecule therapies for oncology patients using a covalent ligand discovery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nexo Therapeutics Comparables
Compare Nexo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Totus Medicines | 89% | |
| Covant Therapeutics | 87% | |
| BridGene Biosciences | 87% | |
Nexo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 27, 2026 | ||||
| Series A | Jul 26, 2023 |
Nexo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Enterprise Associates (NEA) | Series A |
| Cormorant Asset Management | Series A |
| Versant Ventures | Series A |
| Cormorant Asset Management | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors grew 64% MoM.
- Jul 26, 2023
$60M round completed.
Nexo Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nexo Therapeutics's valuation, stock price, and market status.